BSEInsider Trading / SAST29 Sept 2026 · 29 Sept 2026, 03:21 pm
Closure of Trading Window
Vanta Bioscience Ltd · 540729
✦ AI Summary
Vanta Bioscience Ltd has announced the closure of its trading window for all designated persons, their immediate relatives, and other concerned persons, effective from October 01, 2026, until 48 hours after the declaration of unaudited financial results for the half year ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Vanta Bioscience Ltd - 540729 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
a2e95c0e-61d6-46bc-81ab-ae1efd8af2d8.pdf
View document text
29.09.2026
Secunderabad
The Corporate Relations Dept,
BSE Limited
P.J. Towers, Dalal Street,
Mumbai - 400001
Subject: Intimation of Closure of Trading Window
Ref: Scrip Code: 540729 | Scrip ID: VANTABIO
Dear Sir/Madam
In accordance with the Company’s Code of Conduct for Prohibition of Insider Trading and
Pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, as
amended (“SEBI PIT Regulations”), the trading window for transaction in shares of the
Company shall remain closed for all designated persons, their immediate relatives, and all other
concerned persons, with effect from Thursday, October 01, 2026 till the expiry of 48 hours after
the declaration of the Unaudited Financial Results of the Company for the half year ended
September 30, 2026.
The date of the board meeting of the Company, for consideration and declaration of the
Unaudited Financial Results of the Company for the half year ended September 30, 2026 shall
be intimated in due course.
This is for your information and dissemination to general public.
Thanking you,
Yours faithfully,
FOR VANTA BIOSCIENCE LIMITED
DOPESH RAJA MULAKALA
MANAGING DIRECTOR